arrow
A

Ami V. Desai

Dana-Farber Cancer Institute
H指数:24
被引数:2,087

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development and pilot testing of AYA-RISE, a risk information and screening education intervention for adolescents and young adults with cancer risk syndromes

AYA-RISE的开发与试点测试,一种针对具有癌症风险综合征的青少年及年轻成人的风险信息与筛查教育干预

2026-01-230
OAAI
Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter Study

急性毒性和串联自体干细胞移植在儿童高危神经母细胞瘤中的早期结果:一项多中心研究

2025-11-120
PRE
Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions

entrectinib在颅外实体或中枢神经系统 (CNS) 肿瘤携带NTRK或ROS1融合的儿童中的疗效和安全性

2025-02-010
OAAI
EFFICACY AND SAFETY OF ENTRECTINIB IN CHILDREN WITHNTRK ORROS1 FUSION-POSITIVE (FP) PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS
2024-06-180
OAAI
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results
2023-04-0346
OAAI
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)
2022-04-0856
OAAI
Disruption of pancreatic stellate cell myofibroblast phenotype promotes pancreatic tumor invasion
2022-01-0148
OAAI
Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk Neuroblastoma

贫困和靶向免疫治疗: 高危神经母细胞瘤的儿童肿瘤学组临床试验的生存率

2020-11-2446
OAAI
The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy
2019-07-3076
OAAI